"P(GA305/04/0896), P(KSK5011112), Z(AV0Z50040507)" . . "Carvedilol (0,1 uM - 100 uM) v koncentra\u010Dn\u00ED z\u00E1vislosti sni\u017Eoval spont\u00E1nn\u00ED a tak\u00E9 aktivovanou produkci reaktivn\u00EDch kysl\u00EDkov\u00FDch metabolit\u016F m\u011B\u0159enou chemiluminescen\u010Dn\u00ED metodou. Stupe\u0148 t\u00E9to inhibice byl z\u00E1visl\u00FD na typu pou\u017Eit\u00E9ho aktiv\u00E1toru. To nasv\u011Bd\u010Duje tomu, \u017Ee carvedilol, vedle sv\u00FDch antioxida\u010Dn\u00EDch vlastnost\u00ED, zasahuje metabolickou cestu aktivace NADPH oxid\u00E1zy."@cs . "Lojek, Anton\u00EDn" . "The influence of carvedilol on the production of reactive oxygen and nitrogen species by phagocytes" . . "Vliv carvedilolu na produkci kysl\u00EDkov\u00FDch a dus\u00EDkov\u00FDch metabolit\u016F fagocyty"@cs . . "SK - Slovensk\u00E1 republika" . "Vliv carvedilolu na produkci kysl\u00EDkov\u00FDch a dus\u00EDkov\u00FDch metabolit\u016F fagocyty"@cs . . "0006-3088" . "Ma\u010Di\u010Dkov\u00E1, Tatiana" . . "6"^^ . . . . . . "RIV/68081707:_____/05:00026063!RIV06-AV0-68081707" . "1;9" . "The influence of carvedilol on the production of reactive oxygen and nitrogen species by phagocytes"@en . "4"^^ . . "The influence of carvedilol on the production of reactive oxygen and nitrogen species by phagocytes"@en . . "The influence of carvedilol on the production of reactive oxygen and nitrogen species by phagocytes" . "[D1363250D8D8]" . "Gallov\u00E1, Lucie" . "Carvedilol (0.1 uM - 100 uM) dose-dependently inhibited both the spontaneous and the activated CL of phagocytes, although the effect of carvedilol was also dependent on the type of activator. This suggests that carvedilol, besides its antioxidative properties, affects the metabolic pathway of NADPH oxidase activation." . "Pavelkov\u00E1, Martina" . "53" . "-" . "Biologia" . . . . "macrophage; chemiluminescence; nitric oxide synthase"@en . "RIV/68081707:_____/05:00026063" . "\u010C\u00ED\u017E, Milan" . "Nos\u00E1l, Radom\u00EDr" . "524643" . . . "9"^^ . . . "Carvedilol (0.1 uM - 100 uM) dose-dependently inhibited both the spontaneous and the activated CL of phagocytes, although the effect of carvedilol was also dependent on the type of activator. This suggests that carvedilol, besides its antioxidative properties, affects the metabolic pathway of NADPH oxidase activation."@en . . .